Bio-IT World picked up an article in HPCwire last week:
The advancement of genomics and proteomics via high-performance computing is drawing new companies into the drug discovery business. One such company, Gencom Inc., has developed a drug discovery platform based on the Intel Itanium 2 hardware. At April’s Intel Developer’s Forum, Gencom received an Honorable Mention in the Itanium Solutions Alliance’s Humanitarian Impact awards for its use of Itanium to advance functional genomics.
The system operates on Microsoft-based technologies. The interview is interesting in that it provides some insight into how a system like this evolves from concept to production. HPCwire article here.